Imiquimod, a Topical Immune Response Modifier, in the Treatment of Cutaneous Metastases of Malignant Melanoma

Publisher： Karger

E-ISSN： 1421-9832|205|2|135-138

ISSN： 1018-8665

Source： Dermatology, Vol.205, Iss.2, 2002-08, pp. : 135-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topical Treatment of Lentigo maligna Melanoma with Imiquimod 5% Cream

By  

Dermatology, Vol. 207, Iss. 3, 2003-10 ,pp. : 326-328

Karger

Access to resources Recommend Favorite

Topical Immunotherapy with Diphenylcyclopropenone in Combination with DTIC and Radiation for Cutaneous Metastases of Melanoma

By  

Dermatology, Vol. 211, Iss. 4, 2005-12 ,pp. : 370-371

Karger

Access to resources Recommend Favorite

Topical Imiquimod Treatment of Lentigo Maligna

By  

Case Reports in Dermatology, Vol. 1, Iss. 1, 2009-10 ,pp. : 78-81

Karger

Access to resources Recommend Favorite

Topical 5% Imiquimod Long-Term Treatment of Cutaneous Warts Resistant to Standard Therapy Modalities

By  

Dermatology, Vol. 205, Iss. 2, 2002-08 ,pp. : 139-145

Karger

Access to resources Recommend Favorite

Management of Cutaneous Locoregional Recurrences of Melanoma: A New Therapeutic Perspective with Imiquimod

By  

Dermatology, Vol. 206, Iss. 3, 2003-04 ,pp. : 279-280

Karger

Access to resources Recommend Favorite